Has Eric Rishe received payments from drug or device companies?

Yes. Drug and device makers reported $27,330 in general payments to Eric Rishe across 567 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eric Rishe did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eric Rishe come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eric Rishe

Hematology & Oncology · Pembroke Pines, FLNPI 1023133550

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (49.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 58 manufacturers reported payments, led by Amarin Pharma, Inc. at 54.5% of the total. Reporting peaked in 2019 at $11,894 and has fallen 91.2% since, to $1,045 in 2025.

$27,330in general payments, 2019–2025

Across 567 payments — averaging $48.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amarin Pharma, Inc.$15K
Johnson & Johnson$2K
E.r. Squibb & Sons, L.L.C.$1K
Pfizer$873
Macrogenics, Inc.$819
AstraZeneca$690
plus $7K from 52 others

What the payments were for

Consulting fees$8003%
Speaking & faculty fees$13,57050%
Travel & lodging$6802%
Food & beverage$11,78243%
Education$4982%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amarin Pharma, Inc.	25	$14,891
Johnson & Johnson(2 entities)	85	$1,656
E.r. Squibb & Sons, L.L.C.	54	$1,263
Pfizer	44	$873
Macrogenics, Inc.	2	$819
AstraZeneca(2 entities)	34	$690
Novartis	36	$652
Bristol Myers Squibb	30	$582
Sanofi	10	$551
Merck	28	$545
Rigel Pharmaceuticals, Inc.	13	$507
Lilly USA, LLC	19	$389
AbbVie	20	$388
GSK	18	$372
Incyte Corporation	15	$353
Seagen Inc.	13	$254
Eisai Inc.	9	$206
Daiichi Sankyo Inc.	7	$163
Tempus AI, Inc	8	$143
Jazz Pharmaceuticals Inc.	7	$139
Karyopharm Therapeutics Inc.	6	$137
Myriad Genetic Laboratories, Inc.	6	$137
Genentech USA, Inc.	6	$128
Astellas Pharma US Inc	7	$117
Caris MPI, Inc.	1	$108
Amgen	5	$94
Ipsen Biopharmaceuticals, Inc	5	$89
Mirati Therapeutics, Inc.	4	$82
EMD Serono, Inc.	3	$81
Dova Pharmaceuticals	3	$58
Adaptive Biotechnologies Corporation	3	$55
Regeneron Healthcare Solutions, Inc.	2	$53
Taiho Oncology, Inc.	3	$52
Clovis Oncology, Inc.	3	$47
Takeda Pharmaceuticals U.S.A., Inc.	2	$47
Genmab U.S., Inc.	2	$45
Gilead(2 entities)	2	$45
Array Biopharma Inc	2	$42
Deciphera Pharmaceuticals Inc.	2	$41
Octapharma USA, Inc.	2	$39
Amneal Pharmaceuticals LLC	2	$35
Teva Pharmaceuticals USA, Inc.	2	$32
Boston Scientific	1	$30
Organon	2	$29
Dendreon Pharmaceuticals LLC	1	$28
Mylan Institutional Inc.	1	$25
Global Blood Therapeutics, Inc.	1	$23
Bayer	1	$22
Sirtex Medical Inc	1	$21
Cumberland Pharmaceuticals, Inc.	1	$19
Agios Pharmaceuticals, Inc.	1	$19
Spectrum Pharmaceuticals Inc.	1	$19
Advanced Accelerator Applications	1	$19
Heron Therapeutics, Inc.	1	$17
Shield Therapeutics Inc	1	$17
Menarini Silicon Biosystems, Inc.	1	$15
Recordati_rare_diseases_inc.	1	$14
Blueprint Medicines Corporation	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,330 in reported general payments places this provider in the 75th percentile of 694 hematology & oncology providers in Florida.

See all hematology & oncology providers in Florida →

Other hematology & oncology in Pembroke Pines

Jose Sandoval-SusPembroke Pines$131K
Luis RaezPembroke Pines$116K
Martin DietrichRockledge$6.2M
Mark SocinskiOrlando$2.4M
Tarek MekhailOrlando$2.2M
Edgardo SantosFort Lauderdale$2M
Daniel LandauOrlando$1.8M
Wassim McHaylehAltamonte Springs$1.5M
Edith PerezJacksonville$1.1M
Steven FeinMiami$1M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →